Vote Scores
Filings read through

How funds voted at Vertex Pharmaceuticals Incorporated

Filers reporting
1,521, year to 30 June 2026
Latest meeting on file
Meetings on file
5

In the year to 30 June 2026, 1,521 filers on Form N-PX reported votes at Vertex Pharmaceuticals Incorporated. The votes fall in 3 meetings. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 3,063 marks to the ballot items, each with or against management. 89.1% of the marks are with management.

On say-on-pay, 98 of the 1,452 reporting filers that marked the item voted against management. This is 6.7% of the filers. Of the reported shares, 3.9% went against management. The median of the 3,799 companies on this site with a say-on-pay item is 6.6% of filers and 2.9% of reported shares.

At the meeting of 13 May 2026, 54 fund families have a say-on-pay position with management and 1 has a position against management.

By filers reporting in the year to 30 June 2026, Vertex Pharmaceuticals Incorporated was number 130 of 11,972 companies with a page and votes in that year. The number of filers reporting at Vertex Pharmaceuticals Incorporated rose by 0.6% from the year to 30 June 2025 to the year to 30 June 2026. At the companies on this site with filers in both years, the total of filers reporting rose by 6.0%. In all seasons on file, category DIRECTOR ELECTIONS is 67.5% of the vote records at Vertex Pharmaceuticals Incorporated. At all companies on this site, it is 52.2%.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 13 May 2026

1,509 filers reported votes at this meeting in the year to 30 June 2026. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

  1. Item 1: Director elections

    10 nominees. 93.9% of the reported votes are for. 99 filers withheld from or voted against at least one nominee.

    11,737 vote records from 400 filers. 5 of the 399 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 54 fund families
    • For 54
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    2,570 vote records from 1,494 filers. 98 of the 1,452 filers that marked the item voted against management. 42 filers gave no management mark.

    • Positions of 55 fund families
    • For 54
    • Against 1
    • Against management 1
  3. Item 3: Audit-related items (auditor ratification)

    1,139 vote records from 399 filers. 6 of the 398 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 54 fund families
    • For 54
  4. Item 4: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    1,189 vote records from 407 filers. 14 of the 404 filers that marked the item voted against management. 3 filers gave no management mark.

    • Positions of 54 fund families
    • For 52
    • Against 2
    • Against management 2
  5. Item 5: Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written...

    1,089 vote records from 382 filers. 200 of the 382 filers that marked the item voted against management.

    • Positions of 54 fund families
    • For 27
    • Against 27
    • Against management 27
  6. Item 6: Shareholder proposals (not separable from the filings)

    • Proposed by a security holder
    • Several categories

    Filers described these proposals in different words that the site could not match, so they are shown together.

    22 vote records from 13 filers. 7 of the 11 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 2 fund families
    • Against 1
    • Split or no vote 1
    • Against management 1

Positions of the fund families at the meeting of 13 May 2026

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

  • Proposal A: Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written...

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Vertex Pharmaceuticals Incorporated, meeting of 13 May 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund familySay-on-payProposal A
AllianceBernsteinForFor, against management
AllspringForAgainst
American CenturyForAgainst
BairdForNo report
BlackRock and iSharesForAgainst
BNY MellonForFor, against management
Brighthouse FundsForAgainst
Capital Group and American FundsForFor, against management
Charles SchwabForAgainst
Columbia ThreadneedleForFor, against management
DimensionalForAgainst
DWSAgainst, against managementFor, against management
EquitableForFor, against management
Federated HermesForAgainst
FidelityForAgainst
First TrustForFor, against management
Franklin TempletonForFor, against management
Global XForFor, against management
Goldman SachsForAgainst
Guggenheim and RydexForFor, against management
Harbor FundsForAgainst
Hartford FundsForFor, against management
InvescoForFor, against management
J.P. MorganForAgainst
Jackson National fundsForFor, against management
Janus HendersonForAgainst
John Hancock and ManulifeForFor, against management
Lincoln FinancialForFor, against management
Lord AbbettForAgainst
Macquarie and Delaware FundsForFor, against management
MassMutualForAgainst
MFSForFor, against management
Morgan Stanley, Eaton Vance and CalvertForFor, against management
NationwideForAgainst
Natixis and Loomis SaylesForAgainst
Neuberger BermanForAgainst
Northern Trust and FlexSharesForAgainst
Nuveen and TIAAForAgainst
Pacific Life fundsForAgainst
PGIM and PrudentialForAgainst
PIMCOForFor, against management
PrincipalForAgainst
ProShares and ProFundsForFor, against management
Russell InvestmentsForFor, against management
SEIForFor, against management
State Street and SPDRForAgainst
T. Rowe PriceForAgainst
ThriventForAgainst
TransamericaForFor, against management
VanEckForFor, against management
VanguardForAgainst
Victory CapitalForFor, against management
VirtusForFor, against management
VoyaForAgainst
WisdomTreeForFor, against management

Every meeting on file

Meetings of Vertex Pharmaceuticals Incorporated, from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 20261,50966.7%
year to 30 June 2026420.0%
year to 30 June 20251,498710.9%
year to 30 June 20241,48877.2%
year to 30 June 2024320.0%

Say-on-pay, season by season

Say-on-pay at Vertex Pharmaceuticals Incorporated: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 20261,5216.7%3.9%
year to 30 June 20251,51210.9%6.4%
year to 30 June 20241,4937.2%withheld
Vertex Pharmaceuticals Incorporated and the median of companies on this site, year to 30 June 2026
Say-on-payThis companyMedian of companies on this site
Filers against management6.7%6.6%
Reported shares against management3.9%2.9%

The median covers 3,799 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at Vertex Pharmaceuticals Incorporated by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS37,02767.5%
SECTION 14A SAY-ON-PAY VOTES8,49215.5%
AUDIT-RELATED3,4476.3%
SHAREHOLDER RIGHTS AND DEFENSES390.1%
COMPENSATION2,4154.4%
CORPORATE GOVERNANCE2,2764.1%
DIVERSITY, EQUITY, AND INCLUSION1,1892.2%

The record at the SEC

Each link loaded on .

Embed this card on your site

Copy this code into your page. The card shows the figures above with their source. A line under the card links to this page.

How embedding works. It is free. Keep the link in the card and the link line under it.

Cite this page

Vote Scores. How funds voted at Vertex Pharmaceuticals Incorporated. https://votescores.com/company/vertex-pharmaceuticals-incorporated/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of Vertex Pharmaceuticals Incorporated are on file?
5 meetings are on file, from 18 Mar 2024 to 13 May 2026. 3 meetings have 20 or more reporting filers and have their own page.
Did filers report proposals from security holders at Vertex Pharmaceuticals Incorporated?
Filers reported 1 proposal from security holders that the site could tell apart in the year to 30 June 2026. They fall in 1 meeting. The ballot on this page shows each proposal.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Vertex Pharmaceuticals Incorporated reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Vertex Pharmaceuticals Incorporated, grouped by company. The name is the most common spelling among filers. The filers wrote the filings. Filings read through .